Venture Corporation Ltd
SGX:V03
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Venture Corporation Ltd
SGX:V03
|
SG |
|
A
|
Alliance Pharma PLC
LSE:APH
|
UK |
|
MacroGenics Inc
NASDAQ:MGNX
|
US |
|
Simon Property Group Inc
NYSE:SPG
|
US |
|
C
|
Core Laboratories Inc
F:HJ1
|
US |
|
G
|
GEA Group AG
DUS:G1A
|
DE |
|
OPKO Health Inc
NASDAQ:OPK
|
US |
|
U
|
Umbrella Solar Investment SA
MAD:USI
|
ES |
|
B
|
Becton Dickinson and Co
SWB:BOX
|
US |
Wall St Price Targets
V03 Price Targets Summary
Venture Corporation Ltd
According to Wall Street analysts, the average 1-year price target for V03 is 19.42 SGD with a low forecast of 10.59 SGD and a high forecast of 23.21 SGD.
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
What is V03's stock price target?
Price Target
19.42
SGD
According to Wall Street analysts, the average 1-year price target for V03 is 19.42 SGD with a low forecast of 10.59 SGD and a high forecast of 23.21 SGD.
What is the Revenue forecast for Venture Corporation Ltd?
Projected CAGR
5%
Over the last 14 years, the compound annual growth rate for Revenue has been 0%. The projected CAGR for the next 3 years is 5%.
What is the Operating Income forecast for Venture Corporation Ltd?
Projected CAGR
7%
Over the last 14 years, the compound annual growth rate for Operating Income has been 4%. The projected CAGR for the next 3 years is 7%.
What is the Net Income forecast for Venture Corporation Ltd?
Projected CAGR
6%
Over the last 14 years, the compound annual growth rate for Net Income has been 3%. The projected CAGR for the next 3 years is 6%.
